Advertisement
Research Article| Volume 37, ISSUE 11, P2572-2580, November 01, 2015

Download started.

Ok

Adherence to Immunosuppressive Medication in Renal Transplant Recipients From Follow-up Outpatient in China: Association of 2 Different Measurement Methods

  • Jia Liu
    Correspondence
    Address correspondence to: Jin Yan, RN, PhD, Nursing School of Central South University, Research Center of Chinese Health Ministry on Transplantation Medicine Engineering and Technology, The Third Affiliated Hospital, Central South University, Changsha, Hunan, China.
    Affiliations
    Nursing School of Central South University, Research Center of Chinese Health Ministry on Transplantation Medicine Engineering and Technology, The Third Affiliated Hospital, Central South University, Changsha, Hunan, China
    Search for articles by this author
  • Shan Liu
    Affiliations
    Adelphi University College of Nursing and Public Health, Garden City, New York
    Search for articles by this author
  • Jin Yan
    Affiliations
    Nursing School of Central South University, Research Center of Chinese Health Ministry on Transplantation Medicine Engineering and Technology, The Third Affiliated Hospital, Central South University, Changsha, Hunan, China
    Search for articles by this author
  • Qifeng Yi
    Affiliations
    Nursing Teaching and Reaching Office, The Third Affiliated Hospital, Central South University, Changsha, Hunan, China
    Search for articles by this author
  • Hui Huang
    Affiliations
    Nursing Teaching and Reaching Office, The Third Affiliated Hospital, Central South University, Changsha, Hunan, China
    Search for articles by this author

      Abstract

      Purpose

      Our aim was to investigate the association between self-report measure and serum concentration fluctuation of immunosuppressive medication (IM) in renal transplant recipients in China and examine the relationship between post-transplantation time and IM adherence.

      Methods

      Renal transplant recipients at least 3 months post transplantation were recruited from a follow-up outpatient clinic. Both self-reported Morisky Medication Adherence Scale and serum concentration of IM (cyclosporine trough level and tacrolimus trough level) were used to measure drug adherence.

      Findings

      Two hundred and nine patients were recruited in the study. The majority of the patients received grafts from deceased donors (70.3%), were male (63.2%), and were married (83.3%). The nonadherence to IM was 31.7%, as measured by the Morisky Medication Adherence Scale. A statistically significant association between self-reported adherence and serum concentration fluctuation of tacrolimus trough level was identified (P < 0.001), but not for cyclosporine (P = 0.997). Serum concentration fluctuation of tacrolimus trough levels and self-report adherence of IM were associated with transplantation time (P < 0.001 and P = 0.003, respectively).

      Implications

      The Morisky Medication Adherence Scale appears valid in measuring drug adherence when compared with serum concentration fluctuation. Both self-report questionnaire and serum concentration fluctuation of tacrolimus changed with different post-transplantation time. These 2 measurements could be integrated into routine clinical practice for renal transplant recipients.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Clinical Therapeutics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Eknoyan G.
        • Lameire N.
        • Barsoum R.
        • et al.
        The burden of kidney disease: improving global outcomes.
        Kidney Int. 2004; 66: 1310-1314
        • Coresh J.
        • Selvin E.
        • Stevens L.A.
        • et al.
        Prevalence of chronic kidney disease in the United States.
        JAMA. 2007; 298: 2038-2047
        • Khan S.
        • Amedia Jr, C.A.
        Economic burden of chronic kidney disease.
        J Eval Clin Pract. 2008; 14: 422-434
        • Howard K.
        • Salkeid G.
        • White S.
        • et al.
        The cost-effectiveness of increasing kidney transplantation and home-based dialysis.
        Nephrology (Carlton). 2009; 14: 123-132
        • Morrissey P.E.
        • Flynn M.L.
        • Lin S.
        Medication noncompliance and its implications in transplant recipients.
        Drugs. 2007; 67: 1463-1481
        • Nevins T.E.
        • Thomas W.
        Quantitative patterns of azathioprine adherence after renal transplantation.
        Transplantation. 2009; 87: 711-718
        • World Health Organization
        Adherence to long-term therapies: evidence for action.
        WHO, Geneva2015
        • Bosworth H.B.
        • Olsen M.K.
        • Dudley T.
        • et al.
        The Take Control of Your Blood pressure (TCYB) study: study design and methodology.
        Contemp Clin Trials. 2007; 28: 33-47
        • Denhaerynck K.
        • Steiger J.
        • Bock A.
        • et al.
        Prevalence and risk factors of non-adherence with immunosuppressive medication in kidney transplant patients.
        Am J Transplant. 2007; 7: 108-116
        • Butler J.A.
        • Roderick P.
        • Mullee M.
        • et al.
        Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review.
        Transplantation. 2004; 77: 769-776
        • Denhaerynck K.
        • Dobbels F.
        • Cleemput I.
        • et al.
        Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review.
        Transpl Int. 2005; 18: 1121-1133
        • Schäfer-Keller P.
        • Steiger J.
        • Bock A.
        • et al.
        Diagnostic accuracy of measurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients.
        Am J Transplant. 2008; 8: 616-626
        • Brahm M.M.
        • Manfro R.C.
        • Mello D.
        • et al.
        Evaluation of adherence to immunosuppressive drugs in kidney transplantation by control of medication dispensing.
        Transplant Proc. 2012; 44: 2391-2393
        • Weng F.L.
        • Chandwani S.
        • Kurtyka K.M.
        • et al.
        Prevalence and correlates of medication non-adherence among kidney transplant recipients more than 6 months post-transplant: a cross-sectional study.
        BMC Nephrol. 2013; 14: 261
        • Dew M.A.
        • DiMartini A.F.
        • De Vito Dabbs A.
        • et al.
        Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation.
        Transplantation. 2007; 83: 858-873
        • Williams A.F.
        • Manias E.
        • Gaskin C.J.
        • Crawford K.
        Medicine non-adherence in kidney transplantation.
        J Ren Care. 2014; 40: 107-116
        • Walsh J.C.
        • Mandalia S.
        • Gazzard B.G.
        Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome.
        AIDS. 2002; 16: 269-277
        • Russell C.L.
        • Conn V.S.
        • Ashbaugh C.
        • et al.
        Medication adherence patterns in adult renal transplant recipients.
        Res Nurs Health. 2006; 29: 521-532
        • Annunziato R.A.
        • Emre S.
        • Shneider B.
        • et al.
        Adherence and medical outcomes in pediatric liver transplant recipients who transition to adult services.
        Pediatr Transplant. 2007; 11: 608-614
        • Hardstaff R.
        • Green K.
        • Talbot D.
        Measurement of compliance posttransplantation--the results of a 12-month study using electronic monitoring.
        Transplant Proc. 2003; 35: 796-797
        • Hansen R.
        • Seifeldin R.
        • Noe L.
        Medication adherence in chronic disease: issues in posttransplant immunosuppression.
        Transplant Proc. 2007; 39: 1287-1300
        • Ye Q.F.
        • Ming Y.Z.
        Essentials You Need to Know after Kidney Transplantation.
        Central South University Press, Changsha, China2007
        • Morisky D.E.
        • Green L.W.
        • Levine D.M.
        Concurrent and predictive validity of a self-reported measure of medication adherence.
        Med Care. 1986; 24: 67-74
        • Dai J.M.
        • et al.
        The study on the compliance of patients with antihypertensive therapy and influence factors in community.
        Chin J Prev Cont Chron Dis. 2000; 8: 253-255
        • Li K.
        • et al.
        Validity and reliability of the Morisky Questionnaire in assessing antihypertensive therapy compliance of hypertension patients in community.
        Chin J Hypertension. 2010; 18: 1067-1070
        • Juan L.
        • et al.
        The relationship between oral load and medicine adherence in renal transplant patients.
        Shandong Med J. 2013; 53: 87-88
        • Ponticelli C.
        Present and future of immunosuppressive therapy in kidney transplantation.
        Transplant Proc. 2011; 43: 2439-2440
        • Yamaguchi K.
        • Fukuoka N.
        • Kimura S.
        • et al.
        Limited sampling strategy for the estimation of mycophenolic acid area under the concentration-time curve treated in Japanese living-related renal transplant recipients with concomitant extended-release tacrolimus.
        Biol Pharm Bull. 2013; 36: 1036-1039
        • Rostami Z.
        • Einollahi B.
        • Morshedi J.
        • Teimoori M.
        Optimal blood concentration of cyclosporine among Iranian kidney transplant recipients.
        Iran J Kidney Dis. 2012; 6: 373-379
      1. Province, S.I.o.H., www.hntj.gov.cn/fxbg/2015fxbg/2015jmxx/201502/t20150226_115099.htm. 2015.

        • Xia S.S.
        Contemporary Organ Transplantation.
        Peopleʼs Medical Publishing House, Shelton, CT2011
        • Liu G.
        • Li X.
        • Liu T.
        • et al.
        Gender disparity of living donor renal transplantation in East China.
        Clin Transplant. 2013; 27: 98-103
        • Tang X.N.
        • Xue W.J.
        • Gu W.
        The investment of adherence in renal transplantation.
        Chin J Nurs. 2005; 40: 19-21
        • Liu H.X.
        • et al.
        Correlation between medication compliance and health-related quality of life of kidney transplant recipient.
        J Nurs (China). 2015; 22: 33-37
        • Teng S.
        • et al.
        The effects of cognitive-behavior interventions on medication adherence in patients after kidney transplantation: a systematic review.
        J Nurs Admin. 2015; 15: 60-70
        • Ruppar T.M.
        • Russell C.L.
        Medication adherence in successful kidney transplant recipients.
        Prog Transplant. 2009; 19: 167-172
        • Butler J.A.
        • Peveler R.C.
        • Roderick P.
        • et al.
        Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring.
        Transplantation. 2004; 77: 786-789
        • Nevins T.E.
        • Kruse L.
        • Skeans M.A.
        • Thomas W.
        The natural history of azathioprine compliance after renal transplantation.
        Kidney Int. 2001; 60: 1565-1570
        • Hatakeyama S.
        • Fujita T.
        • Yoneyama T.
        • et al.
        A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
        Transplant Proc. 2012; 44: 121-123
        • Nakamura Y.
        • Hama K.
        • Katayama H.
        • et al.
        Safety and efficacy of conversion from twice-daily tacrolimus (prograf) to once-daily prolonged-release tacrolimus (graceptor) in stable kidney transplant recipients.
        Transplant Proc. 2012; 44: 124-127
        • Shemesh E.
        • Shneider B.L.
        • Savitzky J.K.
        • et al.
        Medication adherence in pediatric and adolescent liver transplant recipients.
        Pediatrics. 2004; 113: 825-832
        • Yi X.H.
        Drug utilization and compliance in patients with hypertension.
        China Health Care Nutr. 2013; 23: 56-58